Skip to content

The effect of cognitive hypnotherapy in preventing the relapse of opium use in men treated with methadone

Investigating the effect of cognitive hypnotherapy (COGNITIVE HYPNOTHERAPY) in preventing the relapse of opium use in men treated with methadone compared to the control group in the addiction treatment center.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170108031818N4
Enrollment
38
Registered
2023-05-20
Start date
2023-06-10
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Men treated with methadone.

Interventions

Intervention 1: Intervention group: For the cognitive hypnotherapy intervention group, including 8 sessions of 60 minutes (the number of people in each session is maximum 8 people), it will be held on

Sponsors

Gorgan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: All opium consuming men who have completed a one-month detoxification course and are undergoing maintenance treatment with methadone and have a file in the addiction treatment center affiliated to 5 Azar Hospital in Gorgan. Age 18–55 years Not using other drugs and narcotic drugs for a month before At least elementary education No history of stimulant drug use

Exclusion criteria

Exclusion criteria: Absence of more than 2 sessions of cognitive hypnotherapy Non-cooperation of the patient to monitor the urine test before intervention, after cognitive hypnotherapy and 3 months and 6 months after treatment sessions. Serious medical illness or major psychiatric disorder (depression, psychosis, etc.) based on a clinical interview by a psychiatric assistant

Design outcomes

Primary

MeasureTime frame
Opium relapse. Timepoint: 3 months later and 6 months later. Method of measurement: The morphine urine test is a multi-drug test, and if morphine is positive in this test, it is considered as a relapse of drug abuse.

Secondary

MeasureTime frame
Impulsiveness. Timepoint: 3 months later and 6 months later. Method of measurement: Ernst Barratt Impulsivity Questionnaire.;Reduced drug cravings. Timepoint: 3 months later and 6 months later. Method of measurement: with the Abbreviated Substance Craving Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Zaman Kamkar

Gorgan University of Medical Sciences

kamkar??@yahoo.com0173215846

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026